In a group of 76 hyperactive boys, the presence of multiple minor physical anomalies (stigmata) was associated with severity of hyperactivity and with a history of childhood hyperactivity in the father or a history of early obstetrical difficulty in the mother. In addition, children with high stigmata scores had higher than normal mean plasma dopamine-β-hydroxylase (DβH) activity. DβH was not related to behavioral activity ratings but specifically to stigmata score. Both imipramine and methylphenidate significantly increased plasma DβH activity; however, clinical improvement did not parallel this change. The authors suggest that these children are an important subgroup within the behaviorally defined, heterogeneous population of hyperactive children.
No takes yet. Share an insight, caveat, or question.
Rapoport et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: